Galena Biopharma (GALE) Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting
5/9/2013 9:59:36 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LAKE OSWEGO, Ore., May 9, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, presented information on the development of a Transmucosal Immediate Release Fentanyl (TIRF) REMS program at the American Pain Society 32nd Annual Scientific Meeting. The event is being held May 8-11, 2013 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
Help employers find you! Check out all the jobs and post your resume.